SARS CoV-2 in deer from Pennsylvania sampled during fall and winter 2021

NewsGuard 100/100 Score

In a recent study posted to the medRxiv* preprint server, researchers examined whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected white-tailed deer could be the new animal reservoir with the potential to spillback new SARS-CoV-2 variants into humans.

Study: Evolutionary Trajectories of SARS-CoV-2 Alpha and Delta Variants in White-Tailed Deer in Pennsylvania. Image Credit: Amy Lutz/Shutterstock
Study: Evolutionary Trajectories of SARS-CoV-2 Alpha and Delta Variants in White-Tailed Deer in Pennsylvania. Image Credit: Amy Lutz/Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Coronavirus disease 2019 (COVID-19) started by spillover from bats to humans in late 2019. Since then, several animal species have become prone to SARS-CoV-2 infection, including white-tailed deer Odocoileus virginianus. Over a million white-tailed deer live across counties of Pennsylvania (PA), United States; several of them became SARS-CoV-2-infected, raising concern that a new animal reservoir for SARS-CoV-2 is under formation from which new variants may spillback into humans.

About the study

In the present study, researchers used quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) to detect SARS-CoV-2 in nasal swab samples of 93 white-tailed deer in Pennsylvania during fall-winter 2021.

The samples were collected within hours of the animal’s death, placed in phosphate-buffered saline (PBS), and stored in commercial refrigerators in field offices. These samples were transferred to the University of Pennsylvania within one week of collection and kept at -80°C until ribonucleic acid (RNA) extraction. The researchers used Chi-squared tests to test for differences in proportions of SARS-CoV-2-positive deer samples by gender, age, and source of deer (volunteer-collected, veterinary technician-collected, hunter-harvested, road-killed, etc.).

The researchers collected human samples following the research protocol reviewed by the University of Pennsylvania Institutional Review Board. They collected samples from COVID-19-hospitalized subjects, asymptomatic subjects, and symptomatic subjects.

Study findings

Of 93 deer samples, 18 (19.3%) were positive for SARS-CoV-2 with a confidence interval (CI) of 95%, and these deer were present in 10 out of 31 Pennsylvania counties surveyed from 2 October 2021 to 27 December 2021. Of 66 volunteer-collected and 27 veterinary technicians-collected deer samples, there were 11 and seven SARS-CoV-2-positives, indicating no difference in the proportion of positives between the two groups.

With a prevalence estimate of 35% in females vs. 7.5% in male deer, the prevalence estimate was higher in female deer; however, there is no data indicating disease symptoms in the study animals. Although, authors noted that deer sampled as road-killed were significantly more likely to be SARS-CoV-2-positive than hunter-harvested 11/66, road-killed 6/13, and other 1/14.

Eight out of 93 samples showed the lowest cycle of threshold (Ct) values in the RT-qPCR, indicating the highest viral RNA levels, thus were subjected to viral whole-genome sequencing (WGS). Subsequently, the authors retrieved seven high-quality genome sequences from deer.

The non-viral genomic sequence reads of deer and human samples were analyzed in parallel. While all deer samples had genomic reads mapped to the deer genome, reads from human samples mapped to the human genome, thus confirming that deer contracted SARS-CoV-2 infection via spillover from human hosts.

The two Alpha sequences sampled from deer in adjoining counties in northeastern PA differed by 45 substitutions, indicating that they were introduced independently into deer and then diversified during transmission within deer. In addition, these deer-derived Alpha genomes appeared, particularly divergent in contrast to the human Alpha genomes sequenced previously in the same region. 

Regarding the Delta variants, two deer genomes were assigned to the AY.103 clade and differed only by seven substitutions. Two other deer SARS-CoV-2 genomes fell under the uncommon AY.88 Delta lineage, with only 0.14% of human-derived PA Delta genomes being AY.88; additionally, the last Delta sample belonged to the AY.5 lineage. 

Taken together, these findings support at least four independent spillovers of SARS-CoV-2 from humans into deer, two of alpha, and two of the delta, although the mechanism of transmission from humans to deer remains incomprehensible.

Conclusions 

The WGS data showed selective persistence of the SARS-CoV-2 Alpha variant in white-tailed deer, although this variant had been replaced by the Delta variant in humans long back. Moreover, deer-derived Alpha isolates were significantly divergent from those in humans showing a distinct evolutionary trajectory in deer. However, there is no scientific evidence explaining how SARS-CoV-2 is evolving in new directions in the deer species. 

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 12 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Neha Mathur

Written by

Neha Mathur

Neha is a digital marketing professional based in Gurugram, India. She has a Master’s degree from the University of Rajasthan with a specialization in Biotechnology in 2008. She has experience in pre-clinical research as part of her research project in The Department of Toxicology at the prestigious Central Drug Research Institute (CDRI), Lucknow, India. She also holds a certification in C++ programming.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mathur, Neha. (2023, May 12). SARS CoV-2 in deer from Pennsylvania sampled during fall and winter 2021. News-Medical. Retrieved on May 02, 2024 from https://www.news-medical.net/news/20220222/SARS-CoV-2-in-deer-from-Pennsylvania-sampled-during-fall-and-winter-2021.aspx.

  • MLA

    Mathur, Neha. "SARS CoV-2 in deer from Pennsylvania sampled during fall and winter 2021". News-Medical. 02 May 2024. <https://www.news-medical.net/news/20220222/SARS-CoV-2-in-deer-from-Pennsylvania-sampled-during-fall-and-winter-2021.aspx>.

  • Chicago

    Mathur, Neha. "SARS CoV-2 in deer from Pennsylvania sampled during fall and winter 2021". News-Medical. https://www.news-medical.net/news/20220222/SARS-CoV-2-in-deer-from-Pennsylvania-sampled-during-fall-and-winter-2021.aspx. (accessed May 02, 2024).

  • Harvard

    Mathur, Neha. 2023. SARS CoV-2 in deer from Pennsylvania sampled during fall and winter 2021. News-Medical, viewed 02 May 2024, https://www.news-medical.net/news/20220222/SARS-CoV-2-in-deer-from-Pennsylvania-sampled-during-fall-and-winter-2021.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New SARS-CoV-2 KP.2 variant defies vaccines with higher spread, study warns